Bioinspired nonheme iron complex that triggers mitochondrial apoptotic signalling pathway specifically for colorectal cancer cells

The activation of dioxygen is the keystone of all forms of aerobic life. Many biological functions rely on the redox versatility of metal ion to perform reductive activation-mediated processes entailing...

Iron chelates in the anticancer therapy

Iron plays a significant role in the metabolism of cancer cells. In comparison with normal cells, neoplastic ones exhibit enhanced vulnerability to iron. Ferric ions target tumor via the ferroptotic death pathway—a process involving the iron-mediated lipid oxidation. Ferric ion occurs in complex forms in the physiological conditions. Apart from iron, ligands are the other factors to affect the biological activity of the iron complexes. In recent decades the role of iron chelates in targeting the growth of the tumor was extensively examined. The ligand may possess a standalone activity to restrict cancer’s growth. However, a wrong choice of the ligand might lead to the enhanced cancer cell’s growth in in vitro studies. The paper aims to review the role of iron complex compounds in the anticancer therapy both in the experimental and clinical applications. The anticancer properties of the iron complex rely both on the stability constant of the complex and the ligand composition. When the stability constant is high, the properties of the drug are unique. However, when the stability constant remains low, both components—ferric ions and ligands, act separately on the cells. In the paper we show how the difference in complex stability implies the action of ligand and ferric ions in the cancer cell. Iron complexation strategy is an interesting attempt to transport the anticancer Fe2+/3+ ions throughout the cell membrane and release it when the pH of the microenvironment changes. Last part of the paper summarizes the results of clinical trials and in vitro studies of novel iron chelates such as: PRLX 93,936, Ferumoxytol, Talactoferrin, DPC, Triapine, VLX600, Tachypyridine, Ciclopiroxamine, Thiosemicarbazone, Deferoxamine and Deferasirox.

Aqueous Dried Extract of Skytanthus acutus Meyen as Corrosion Inhibitor of Carbon Steel in Neutral Chloride Solutions

The implementation of corrosion engineering control methods and techniques is crucial to extend the life of urban and industrial infrastructure assets and industrial equipment affected by natural corrosion. Then, the search of stable and environmentally friendly corrosion inhibitors is an important pending task. Here, we provide experimental evidence on the corrosion inhibitory activity of aqueous extracts of Skytanthus acutus Meyen leaf, a native plant from the Atacama Desert in northern Chile. Skytanthus extracts as a powder should be prepared at 55 °C to avoid thermal decomposition and loss of corrosion inhibitory activity. Corrosion of carbon steel AISI1020 immersed in 0.5 M NaCl was evaluated in the presence of different doses of Skytanthus extract by complementary and simultaneous linear polarization, electrochemical impedance spectroscopy, and weight-loss technique under high hydrodynamic conditions. Mixed Potential Theory was applied to confirm the electrochemical activity of the extract inhibitory capabilities. The Skytanthus extracts reached a 90% corrosion inhibitory efficiency when tested at 100 to 1200 ppm in a time span of 48 h, through an electrochemical interaction between the extract inhibitor component and the carbon steel surface. The corrosion inhibition activity observed in Skytanthus dry extracts involves a protective film formation by a mechanism that includes an iron dissolution at the expense of either oxygen reduction and/or hydrogen evolution, followed by a ferrous-ferric iron cycling, the formation of an iron complex and adsorption to the metal surface, and, finally, desorption or degradation of the protecting film. The water-soluble plant extract was subjected to HPLC-MS analyses that rendered 14 major signals, with quinic acid, protocatechuic acid, chlorogenic acid isomers, vanillic acid hexoside, and patuletin 3-methoxy-7-glucoside as the most abundant components. Then, we propose that a phenolic derivative is responsible for the corrosion inhibitory activity found in Skytanthus extracts.